Fractyl Health Inc. Insider Trading
GUTS
Insiders bought 187K on the open market and sold nothing.
Get an email when GUTS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14 | William Bradley Director | Bought | 64,516 | $0.62 | 40K | 76% | Form 4 |
| Jun 12 | Ajay Royan Director | Bought | 23,000 | $0.85 | 20K | 1.8% | Form 4 |
| Jun 10 | William Bradley Director | Bought | 68,493 | $0.73 | 50K | 425% | Form 4 |
| Jun 10 | Ian Sheffield Director | Bought | 35,000 | $0.73 | 26K | New | Form 4 |
| Jun 10 | Harith Rajagopalan Chief Executive Officer | Bought | 25,000 | $0.73 | 18K | 2.2% | Form 4 |
| Jun 8 | Weber Lara Smith Chief Financial Officer | Bought | 20,000 | $0.69 | 14K | New | Form 4 |
| Dec 4, 2025 | Harith Rajagopalan Chief Executive Officer | Bought | 10,416 | $1.92 | 20K | 1.0% | Form 4 |
| Mar 14, 2025 | Ajay Royan Director | Bought | 17,901 | $1.28 | 23K | 1.4% | Form 4 |
| Mar 14, 2025 | Kelly Ann Barnes Director | Bought | 31,000 | $1.30 | 40K | New | Form 4 |
| Mar 13, 2025 | Amy W Schulman Director | Bought | 8,550 | $1.17 | 10K | New | Form 4 |
| Mar 13, 2025 | William Bradley Director | Bought | 16,129 | $1.26 | 20K | New | Form 4 |
| Mar 13, 2025 | Samuel Conaway Director | Bought | 8,550 | $1.17 | 10K | New | Form 4 |
| Jan 30, 2025 – Jan 31, 2025 | Harith Rajagopalan Chief Executive Officer | Sold10b5-1 plan 2 parts | 111,920 | $1.84 average | 206K | 9.3% | Form 4 |
| Jan 30, 2025 – Jan 31, 2025 | Jay David Caplan President, Chief Product Off. | Sold10b5-1 plan 2 parts | 43,818 | $1.88 average | 82K | 6.5% | Form 4 |
- Sep 14William BradleyDirector · bought 64,516 at $0.6240K76% of stake
- Jun 12Ajay RoyanDirector · bought 23,000 at $0.8520K1.8% of stake
- Jun 10William BradleyDirector · bought 68,493 at $0.7350K425% of stake
- Jun 10Ian SheffieldDirector · bought 35,000 at $0.7326KNew position
- Jun 10Harith RajagopalanChief Executive Officer · bought 25,000 at $0.7318K2.2% of stake
- Jun 8Weber Lara SmithChief Financial Officer · bought 20,000 at $0.6914KNew position
- Dec 4, 2025Harith RajagopalanChief Executive Officer · bought 10,416 at $1.9220K1.0% of stake
- Mar 14, 2025Ajay RoyanDirector · bought 17,901 at $1.2823K1.4% of stake
- Mar 14, 2025Kelly Ann BarnesDirector · bought 31,000 at $1.3040KNew position
- Mar 13, 2025Amy W SchulmanDirector · bought 8,550 at $1.1710KNew position
- Mar 13, 2025William BradleyDirector · bought 16,129 at $1.2620KNew position
- Mar 13, 2025Samuel ConawayDirector · bought 8,550 at $1.1710KNew position
- Jan 30, 2025 – Jan 31, 202510b5-1 planHarith RajagopalanChief Executive Officer · sold 111,920 at avg $1.84206K9.3% of stake
- Jan 30, 2025 – Jan 31, 202510b5-1 planJay David CaplanPresident, Chief Product Off. · sold 43,818 at avg $1.8882K6.5% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with GUTS
Spot a number that looks wrong? Check it in GUTS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GUTS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.